Also trades as: PPBT.TA (TLV) · $vol 0M
PPBT NASDAQ
Purple Biotech Ltd.
1W: +0.0%
1M: -23.7%
3M: -12.7%
YTD: -77.1%
1Y: +157.7%
3Y: -93.4%
5Y: -98.4%
$1.51
-0.01 (-0.66%)
Weekly Expected Move ±9.6%
$1
$1
$2
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$205K
-10.0% ▼
Operating Income
-$7M
+36.1% ▲
Net Income
-$27M
-270.3% ▼
EPS (Diluted)
$-11080.00
-24967.9% ▼
EBITDA
-$7M
+3.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $196K | $0 | $0 |
| YoY Growth | -100.0% | +0.0% | +0.0% | -100.0% | +0.0% |
| Cost of Revenue | $55 | $120 | $196K | $186K | $205K |
| Gross Profit | -$55 | -$120 | -$196 | -$186K | -$205K |
| Gross Margin | — | — | -0.1% | — | — |
| R&D Expenses | $12M | $16M | $17M | $8M | $4M |
| SG&A Expenses | $6M | $6M | $5M | $3M | $3M |
| Operating Expenses | $18M | $23M | -$22M | $11M | $7M |
| Operating Income | -$18M | -$23M | -$22M | -$11M | -$7M |
| Operating Margin | — | — | -11374.1% | — | — |
| Interest Expense | $212K | $67K | $2M | $447K | $990K |
| Income Before Tax | -$18M | -$22M | -$20M | -$7M | -$27M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$18M | -$22M | -$20K | -$7M | -$27M |
| Net Margin | — | — | -10.2% | — | — |
| EPS (Diluted) | $-0.21 | $-0.23 | $-0.16 | $-4.42 | $-11080.00 |
| EBITDA | -$18M | -$21M | -$20M | -$7M | -$7M |
| Shares Outstanding | 890005 | 924075 | 1M | 3M | 2400 |